PetVivo Holdings PETV
OTC PETV
$0.69 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

PetVivo Holdings (PETV) Depreciation & Amortization (CF) (2015 - 2026)

Updated

PetVivo Holdings (PETV) recorded Depreciation & Amortization (CF) of $134,671 in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 14.2% from $117,890 a year earlier but down 0.4% from the prior quarter.

Analysis

PetVivo Holdings (PETV) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

On a TTM basis, PetVivo Holdings' Depreciation & Amortization (CF) came in at $528,238 as of Jun 30, 2026, up 104.0% year-over-year; for FY2026 (ended Mar 31, 2026), it was $511,457, up 192.9% from FY2025.

  • Annual Depreciation & Amortization (CF) has increased for four straight fiscal years, with a five-year compound annual growth rate of 42.6% (FY2021 to FY2026).
  • Across earlier fiscal years, Depreciation & Amortization (CF) came in at $174,590 in FY2025 (+37.6%), $126,850 in FY2024 (+10.8%), $114,434 in FY2023 (+75.6%) and $65,153 in FY2022 (-24.9%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $14,090 in fiscal Q2 2022 to $135,207 in fiscal Q4 2026 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for ten consecutive quarters, with growth averaging 134.5% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 320.0% in fiscal Q3 2026, against a decline of 8.9% in fiscal Q3 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $135,207 (Q4 2026), $134,717 (Q3 2026) and $123,643 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.62 Bn
10 PetVivo Holdings 26.19 Mn 24.93 Mn 223,317.00 134,671.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 134,671.00
Mar 31, 2026 135,207.00
Dec 31, 2025 134,717.00
Sep 30, 2025 123,643.00
Jun 30, 2025 117,890.00
Mar 31, 2025 75,976.00
Dec 31, 2024 32,074.00
Sep 30, 2024 33,043.00
Jun 30, 2024 33,497.00
Mar 31, 2024 33,159.00
Dec 31, 2023 30,327.00
Sep 30, 2023 32,215.00
Jun 30, 2023 31,149.00
Mar 31, 2023 22,649.00
Dec 31, 2022 33,275.00
Sep 30, 2022 30,957.00
Jun 30, 2022 27,553.00
Mar 31, 2022 21,985.00
Dec 31, 2021 15,479.00
Sep 30, 2021 14,090.00
API Access

PetVivo Holdings Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PETV&period=max&api_key=YOUR_API_KEY